These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 28871208)

  • 1. Identify latent chromosomal aberrations relevant to myelodysplastic syndromes.
    Song Q; Chu Y; Yao Y; Peng M; Yang W; Li X; Huang S
    Sci Rep; 2017 Sep; 7(1):10354. PubMed ID: 28871208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence of chromosomal aberrations associated with myelodysplastic syndromes in China.
    Hu Q; Chu Y; Song Q; Yao Y; Yang W; Huang S
    Ann Hematol; 2016 Aug; 95(8):1241-8. PubMed ID: 27225263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-nucleotide polymorphism array (SNP-A) improves the identification of chromosomal abnormalities by metaphase cytogenetics in myelodysplastic syndrome.
    da Silva FB; Machado-Neto JA; Bertini VHLL; Velloso EDRP; Ratis CA; Calado RT; Simões BP; Rego EM; Traina F
    J Clin Pathol; 2017 May; 70(5):435-442. PubMed ID: 27836923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.
    Svobodova K; Zemanova Z; Lhotska H; Novakova M; Podskalska L; Belickova M; Brezinova J; Sarova I; Izakova S; Lizcova L; Berkova A; Siskova M; Jonasova A; Cermak J; Michalova K
    Leuk Res; 2016 Mar; 42():7-12. PubMed ID: 26851439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiplex ligation-dependent probe amplification assay identifies additional copy number changes compared with R-band karyotype and provide more accuracy prognostic information in myelodysplastic syndromes.
    Wang J; Ai X; Qin T; Xu Z; Zhang Y; Liu J; Li B; Fang L; Zhang H; Pan L; Hu N; Qu S; Cai W; Ru K; Jia Y; Huang G; Xiao Z
    Oncotarget; 2017 Jan; 8(1):1603-1612. PubMed ID: 27906673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of complex chromosomal aberrations in patients with myelodysplastic syndromes using multiplex fluorescence in situ hybridization combined with whole chromosome painting].
    Chen LJ; Li JY; Xiao B; Zhu Y; Liu Q; Pan JL; Qiu HR; Fan L; Zhang SJ; Lu RN; Xu W; Xue YQ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):635-9. PubMed ID: 18067073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The utility of fluorescence in situ hybridization analysis in diagnosing myelodysplastic syndromes is limited to cases with karyotype failure.
    Jiang H; Xue Y; Wang Q; Pan J; Wu Y; Zhang J; Bai S; Wang Q; He G; Sun A; Wu D; Chen S
    Leuk Res; 2012 Apr; 36(4):448-52. PubMed ID: 22047706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FISH analysis in addition to G-band karyotyping: utility in evaluation of myelodysplastic syndromes?
    Yang W; Stotler B; Sevilla DW; Emmons FN; Murty VV; Alobeid B; Bhagat G
    Leuk Res; 2010 Apr; 34(4):420-5. PubMed ID: 19800120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytogenetic and comparative genomic hybridization study of Indian myelodysplastic syndromes.
    Kawankar N; Jijina F; Ghosh K; Vundinti BR
    Cancer Epidemiol; 2011 Aug; 35(4):e1-5. PubMed ID: 21193364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone Marrow Conventional Karyotyping and Fluorescence In Situ Hybridization:  Defining an Effective Utilization Strategy for Evaluation of Myelodysplastic Syndromes.
    He R; Wiktor AE; Durnick DK; Kurtin PJ; Van Dyke DL; Tefferi A; Patnaik MS; Ketterling RP; Hanson CA
    Am J Clin Pathol; 2016 Jul; 146(1):86-94. PubMed ID: 27353768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detecting chromosomal aberrations in myelodysplastic syndrome with fluorescence in situ hybridization and conventional cytogenetic analysis].
    Cao P; Li Y; Li X; Zhang G; Chen F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Jun; 39(6):605-11. PubMed ID: 25011965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A comparative study of fluorescence in situ hybridization versus conventional cytogenetics in the detection of clonal aberrations in myelodysplastic syndrome].
    Lai YY; Li N; Feng L; Shi Y; Dang H; He Q; Wang Z; Wang XY; Li Y; Liu Q; Huang XJ
    Zhonghua Yi Xue Za Zhi; 2013 Oct; 93(40):3175-9. PubMed ID: 24405535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-resolution genomic arrays facilitate detection of novel cryptic chromosomal lesions in myelodysplastic syndromes.
    O'Keefe CL; Tiu R; Gondek LP; Powers J; Theil KS; Kalaycio M; Lichtin A; Sekeres MA; Maciejewski JP
    Exp Hematol; 2007 Feb; 35(2):240-51. PubMed ID: 17258073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is fluorescence in-situ hybridization sufficient in patients with myelodysplastic syndromes and insufficient cytogenetic testing?
    Merkel D; Soffer S; Novikov I; Avigdor A; Amariglio N; Nagler A; Trakhtenbrot L
    Leuk Lymphoma; 2019 Mar; 60(3):764-771. PubMed ID: 30187812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosomal Abnormalities in Myelodysplastic Syndrome Patients in Upper Northern Thailand.
    Phrommin S; Tantiworawit A; Rattanathammethee T; Puaninta C; Pangjaidee N; Aungsuchawan S; Bumroongkit K
    Asian Pac J Cancer Prev; 2020 Mar; 21(3):639-645. PubMed ID: 32212788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection of chromosome abnormalities in myelodysplastic syndromes with interval fluorescence in situ hybridization].
    Ru X; Li Q; Fang XS; Li Y; Wang X; Zhang LY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):116-20. PubMed ID: 23484703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do we need to do fluorescence in situ hybridization analysis in myelodysplastic syndromes as often as we do?
    Costa D; Valera S; Carrió A; Arias A; Muñoz C; Rozman M; Belkaid M; Coutinho R; Nomdedeu B; Campo E
    Leuk Res; 2010 Nov; 34(11):1437-41. PubMed ID: 20226525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Karyotype analysis and fluorescence in situ hybridization detection of 122 patients with myelodysplastic syndrome].
    Jing Y; Lin S; Jiang F; Wang F; Fang M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Apr; 33(2):221-6. PubMed ID: 27060321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromothripsis Is a Recurrent Genomic Abnormality in High-Risk Myelodysplastic Syndromes.
    Abáigar M; Robledo C; Benito R; Ramos F; Díez-Campelo M; Hermosín L; Sánchez-Del-Real J; Alonso JM; Cuello R; Megido M; Rodríguez JN; Martín-Núñez G; Aguilar C; Vargas M; Martín AA; García JL; Kohlmann A; Del Cañizo MC; Hernández-Rivas JM
    PLoS One; 2016; 11(10):e0164370. PubMed ID: 27741277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematologic and cytogenetic analyses of 99 cases of de novo myelodysplastic syndromes.
    D'Emilio A; Montaldi A; Stella M; Celli P; Guercini N; Tremul L; Rodeghiero F
    Haematologica; 1993; 78(6 Suppl 2):61-5. PubMed ID: 8039762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.